Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.
Int J Tuberc Lung Dis
; 20(4): 430-4, 2016 Apr.
Article
em En
| MEDLINE
| ID: mdl-26970149
ABSTRACT
BACKGROUND:
Despite renewed focus on molecular tuberculosis (TB) diagnostics and new antimycobacterial agents, treatment outcomes for patients co-infected with drug-resistant TB and human immunodeficiency virus (HIV) remain dismal, in part due to lack of focus on medication adherence as part of a patient-centered continuum of care.OBJECTIVE:
To review current barriers to drug-resistant TB-HIV treatment and propose an alternative model to conventional approaches to treatment support.DISCUSSION:
Current national TB control programs rely heavily on directly observed therapy (DOT) as the centerpiece of treatment delivery and adherence support. Medication adherence and care for drug-resistant TB-HIV could be improved by fully implementing team-based patient-centered care, empowering patients through counseling and support, maintaining a rights-based approach while acknowledging the responsibility of health care systems in providing comprehensive care, and prioritizing critical research gaps.CONCLUSION:
It is time to re-invent our understanding of adherence in drug-resistant TB and HIV by focusing attention on the complex clinical, behavioral, social, and structural needs of affected patients and communities.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Contexto em Saúde:
2_ODS3
/
3_ND
/
4_TD
Problema de saúde:
2_enfermedades_transmissibles
/
3_neglected_diseases
/
3_tuberculosis
/
4_antimicrobial_resistance
/
4_tuberculosis
Assunto principal:
Infecções por HIV
/
Tuberculose Resistente a Múltiplos Medicamentos
/
Assistência Centrada no Paciente
/
Adesão à Medicação
Limite:
Humans
Idioma:
En
Revista:
Int J Tuberc Lung Dis
Ano de publicação:
2016
Tipo de documento:
Article